Improved quality of life with fremanezumab in Japanese and Korean patients with episodic and chronic migraine: Results of two multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trials.

Matsumori, Yasuhiko; Ishida, Miki; Iba, Katsuhiro; Kim, Byung-Kun; Ning, Xiaoping; Nakai, Masami; Koga, Nobuyuki

Matsumori, Yasuhiko; Ishida, Miki; Iba, Katsuhiro; Kim, Byung-Kun; Ning, Xiaoping; Nakai, Masami; Koga, Nobuyuki.

Afiliação

Matsumori Y; Sendai Headache and Neurology Clinic, Sendai, Japan.
Ishida M; Headquarters of Clinical Development, Otsuka Pharmaceutical Co., Ltd., Osaka, Japan.
Iba K; Headquarters of Clinical Development, Otsuka Pharmaceutical Co., Ltd., Osaka, Japan.
Kim BK; Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, Republic of Korea.
Ning X; Teva Branded Pharmaceutical Products R&D, Inc., West Chester, Pennsylvania, USA.
Nakai M; Medical Affairs, Otsuka Pharmaceutical Co., Ltd., Osaka, Japan.
Koga N; Medical Affairs, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.

Headache ; 63(9): 1304-1313, 2023 Oct.

Article em En | MEDLINE | ID: mdl-37602905

Palavras-chave

Japanese; Korean; chronic migraine; episodic migraine; fremanezumab; quality of life

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 Problema de saúde: 2_muertes_prematuras_enfermedades_notrasmisibles Tipo de estudo: Clinical_trials Aspecto: Patient_preference Idioma: En Revista: Headache Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google